Group One Trading, L.P. Fortress Biotech, Inc. Transaction History

Group One Trading, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.65 - $1.1 $1,300 - $2,200	2,000 New	2,000 $1,000
Q2 2022 Aug 11, 2022	BUY	$0.8 - $1.5 $1,600 - $3,000	2,000 New	2,000 $2,000
Q1 2022 May 12, 2022	SELL	$1.24 - $2.75 $18,195 - $40,353	-14,674 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$2.42 - $3.65 $18,876 - $28,470	7,800 Added 113.47%	14,674 $37,000
Q3 2021 Nov 12, 2021	SELL	$2.82 - $3.7 $9,153 - $12,010	-3,246 Reduced 32.08%	6,874 $22,000
Q2 2021 Aug 10, 2021	BUY	$3.5 - $5.48 $35,420 - $55,457	10,120 New	10,120 $36,000

862K

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $185M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.